A pathogenic or likely pathogenic Lynch syndrome variant in any of four genes (MLH1, MSH2, MSH6, and PMS2) was identified in 76 (0.15%) individuals (Supplementary Table 5), conferring an odds ratio for colorectal cancer of 27.86 (95% CI 14.35–54.10). The gene discussed is MSH2; the disease is Lynch syndrome.